跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 82,872 条关于
“dual-agonist GLP-1/GIP therapies”
全部
82,872
临床试验
46,647
药物
8,911
机构
1,596
资讯
25,718
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
11个月前
Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
5个月前
BrightGene's Oral GLP-1/GIP Dual Agonist BGM0504 Shows Promising Weight Loss Results in Phase 1 Trials
去年
Viking Therapeutics Advances Novel Oral GLP-1/GIP Dual Agonist VK2735 to Phase 2 Trial for Obesity Treatment
上个月
Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity
去年
Roche Breaks Ground on $700M North Carolina Manufacturing Facility for Next-Generation Obesity Treatments
去年
Rani Therapeutics Achieves Bioequivalence with Oral GLP-1/GLP-2 Dual Agonist for Obesity Treatment
8个月前
Rani Therapeutics Launches Phase 1 Trial of Oral GLP-1/GLP-2 Dual Agonist RT-114 for Obesity Treatment
去年
Hengrui and Kailera's Dual GLP-1/GIP Obesity Drug Achieves 18% Weight Loss in Phase 3 Trial
第 1 页，共 2572 页
上一页
下一页
